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Editorials 1235 Coming next month: CME online
Andrew S. Wechsler, MD, Editor, Philadelphia, Pa
1236 Religion, politics . . . deep hypothermic circulatory arrest Œ
Frank L. Hanley, MD, Stanford, Calif
Surgery for Acquired
Cardiovascular Disease
(ACD)
1242 A comparison of outcomes of mitral valve repair for degenerative disease
with posterior, anterior, and bileaflet prolapse
Tirone E. David, MD, Joan Ivanov, PhD, Susan Armstrong, MSc, Debbie Christie, RN, and
Harry Rakowski, MD, Toronto, Ontario, Canada
A review of 701 patients who had MV repair for degenerative disease indicated that the
pathophysiology of the MR had an important effect on the durability of the repair. Isolated
posterior leaflet prolapse resulted in lower rates of recurrent MR than anterior or bileaflet
prolapse.
1250 Residual high incidence of ventricular arrhythmias after left ventricular
reconstructive surgery
James O. O’Neill, MB, FRCPI, Randall C. Starling, MD, MPH, FACC, Yaariv Khaykin, MD,
Patrick M. McCarthy, MD, James B. Young, MD, MPH, FACC, Melanie Hail, RN,
Nancy M. Albert, PhD, RN, Nicholas Smedira, MD, and Mina K. Chung, MD, FACC,
Cleveland, Ohio
Of 217 patients who underwent left ventricular reconstruction, survival was 90% (median
follow-up, 381 days), and electrophysiological studies successfully identified patients at low
risk. Appropriate ICD therapies occurred in 20% of patients with ICDs in situ before surgery
and in 12% of patients with postoperative ICDs.
1257 The identification and development of Canadian coronary artery bypass
graft surgery quality indicators
Veena Guru, MD, Geoffrey M. Anderson, Stephen E. Fremes, MD, Gerald T. O’Connor, PhD,
Frederick L. Grover, MD, Jack V. Tu, MD, PhD, and the Canadian CABG Surgery Quality
Indicator Consensus Panel, Toronto, Ontario, Canada, Hanover, NH, and Denver, Colo
Through Delphi consensus paneling, a standard set of measures was developed to evaluate
institutional performance for CABG surgery in Canada. This was compared to a parallel
process in the United States (National Quality Forum). These measures can be used by CABG
providers in an effort to continuously monitor and improve performance.
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1265 Single–suture line placement of a pericardial stentless valve
Alberto Repossini, MD, Igor Kotelnikov, MD, Riad Bouchikhi, MD, Tiziano Torre, MD,
Bruno Passaretti, MD, Oberdan Parodi, MD, and Vincenzo Arena, MD, Bergamo and Pisa,
Italy
A well-established supra-annular implantation technique with a latest-generation pericardial
stentless valve showed excellent safety and reliability, although adequate experience was
required for such results. Clinical outcomes are similar to those obtained with other techniques,
with satisfactory hemodynamic performance.
1270 Risk factors for and economic implications of prolonged ventilation after
cardiac surgery
C. Rajakaruna, MRCS, C. A. Rogers, PhD, G. D. Angelini, MD, FRCS, and
R. Ascione, MD, FRCS, Bristol, United Kingdom
Our objective was to identify predictors of prolonged ventilation and assess clinical and cost
implications in patients undergoing cardiac surgery. We determined that prolonged ventilation
is associated with high in-hospital mortality and costs and poor 5-year survival. Identified
predictors of prolonged ventilation might help to optimize the clinical management of these
patients.
Surgery for Congenital
Heart Disease
(CHD)
1278 Increasing duration of deep hypothermic circulatory arrest is associated
with an increased incidence of postoperative electroencephalographic
seizures Œ
J. William Gaynor, MD, Susan C. Nicolson, MD, Gail P. Jarvik, MD, PhD,
Gil Wernovsky, MD, Lisa M. Montenegro, MD, Nancy B. Burnham, RN, MSN,
Diane M. Hartman, RN, Andy Louie, Thomas L. Spray, MD, and Robert R. Clancy, MD,
Philadelphia, Pa, and Seattle, Wash
Electroencephalographic monitoring demonstrates postoperative seizures in 11% of neonates
and infants after repair of complex congenital heart defects. Increasing duration of DHCA was
identified as a predictor of seizures. However, the incidence of seizures in patients undergoing
limited periods of DHCA was similar to that in patients undergoing continuous CPB.
1287 Aorta–right atrial tunnel: Clinical presentation, diagnostic criteria, and
surgical options
Trushar Gajjar, DNB, Choudary Voleti, MD, FACS, Rekha Matta, MCh, Ramnath Iyer, DNB,
Prabhat Kumar Dash, DM, and Neelam Desai, MCh, DNB, Andhra Pradesh, India
We report 9 cases of aorta–right atrial tunnel, documenting this rare clinical entity’s intriguing
morphology, varying clinical presentation, detailed diagnostic approaches, and challenging
management options. Until now, only 8 such cases have been reported in the literature.
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1293 Laryngopharyngeal dysfunction after the Norwood procedure
Margaret L. Skinner, MD, Lucinda A. Halstead, MD, Catherine S. Rubinstein, MSN, FNP,
Andrew M. Atz, MD, Diane Andrews, SLP, and Scott M. Bradley, MD, Charleston, SC
After a Norwood procedure, fiberoptic laryngoscopy showed left true vocal fold paralysis in 3
(9%) of 33 patients; the results of a modified barium swallow were abnormal in 16 (48%) of
33 patients and showed aspiration in 8 (24%) of 33 patients. Only 1 of 16 patients with
abnormal swallowing had vocal fold paralysis. Routine evaluation of postoperative
laryngopharyngeal function might contribute to decreased hospital and interstage mortality.
Cardiopulmonary
Support and Physiology
(CSP)
1302 Clinical outcomes in patients with chronic congestive heart failure who
undergo left ventricular assist device implantation
Nicholas C. Dang, MD, Veli K. Topkara, MD, Brian T. Kim, BS, Michelle L. Mercando, BS,
Joy Kay, BS, and Yoshifumi Naka, MD, PhD, New York, NY
Left ventricular assist device implantation is a well accepted support option for patients with
chronic congestive heart failure. We characterized clinical outcomes for this unique population
of patients.
1310 Cell transplantation preserves cardiac function after infarction by infarct
stabilization: Augmentation by stem cell factor
Shafie Fazel, MD, MSc, Liwen Chen, MSc, Richard D. Weisel, MD,
Denis Angoulvant, MD, MSc, Charit Seneviratne, PhD, Amir Fazel, BSc, Phillip Cheung, BSc,
Jason Lam, BSc, Paul W. M. Fedak, MD, PhD, Terrence M. Yau, MD, MSc, and
Ren-Ke Li, MD, PhD, Toronto, Ontario, Canada
In a murine model of acute MI and adult stem cell implantation, we show that the benefits to
cardiac function are principally derived from the effect of the cells on the local remodeling of
the infarct, and not from cardiomyocyte regeneration.
1319 Attempted control of hyperglycemia during cardiopulmonary bypass fails to
improve neurologic or neurobehavioral outcomes in patients without
diabetes mellitus undergoing coronary artery bypass grafting
John Butterworth, MD, Lynne E. Wagenknecht, DrPH, Claudine Legault, PhD,
Daniel J. Zaccaro, MS, Neal D. Kon, MD, John W. Hammon, Jr, MD,
Anne T. Rogers, MBChB, B. Todd Troost, MD, David A. Stump, PhD,
Curt D. Furberg, MD, PhD, and Laura H. Coker, PhD, Winston-Salem, NC
Attempted control of hyperglycemia in patients without diabetes mellitus undergoing CPB for
CABG grafting failed to improve neurologic, neuro-ophthalmologic, or neurobehavioral
outcomes.
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1326 The remote ischemic preconditioning stimulus modifies gene expression in
mouse myocardium
Igor E. Konstantinov, MD, PhD, Sara Arab, PhD, Jia Li, MD, PhD, John G. Coles, MD,
Cathy Boscarino, MSc, Alessandro Mori, BSc, Eva Cukerman, BSc, Fayez Dawood, DVM,
Michael M. H. Cheung, MD, Mikiko Shimizu, MD, Peter P. Liu, MD, and
Andrew N. Redington, MD, Toronto, Ontario, Canada
A simple remote ischemic preconditioning stimulus modifies myocardial gene expression by
upregulating cardioprotective genes and suppressing genes potentially involved in the
pathogenesis of ischemia-reperfusion injury.
1333 Repair of impaired myocardium by means of implantation of engineered
autologous myoblast sheets
Imran A. Memon, MBBS, PhD, Yoshiki Sawa, MD, PhD, Norihide Fukushima, MD,
Goro Matsumiya, MD, Shigeru Miyagawa, MD, PhD, Satoshi Taketani, MD,
Satoru K. Sakakida, MD, PhD, Haruhiko Kondoh, MD, PhD, Alexey N. Aleshin, MD, PhD,
Tatsuya Shimizu, MD, PhD, Teruo Okano, PhD, and Hikaru Matsuda, MD, Osaka and Tokyo,
Japan
Tissue-engineered skeletal myoblast cell sheets attenuate cardiac remodeling, with improvement
in cardiac performance.
1342 Circulating big endothelin-1: An active role in pulmonary
thromboendarterectomy?
Frank Langer, MD, Michael Bauer, MD, Dietmar Tscholl, MD, Rene Schramm, MD,
Takashi Kunihara, MD, Henning Lausberg, MD, Thomas Georg, MD, Heinrike Wilkens, MD,
and Hans-Joachim Schäfers, MD, Homburg and Jena, Germany
During the early postoperative course after PTE, pulmonary vasoconstriction and profound
systemic vasodilation may be observed. Preoperative big ET-1 levels correlate with some
aspects of vasoregulation in patients with CTEPH and may be used as a predictor of outcome
after PTE.
Evolving Technology
(ET)
1348 Three-dimensional echo-guided beating heart surgery without
cardiopulmonary bypass: Atrial septal defect closure in a swine model
Yoshihiro Suematsu, MD, PhD, Joseph F. Martinez, DVM, Benjamin K. Wolf, BS,
Gerald R. Marx, MD, Jeffrey A. Stoll, BS, Pierre E. DuPont, PhD, Robert D. Howe, PhD,
John K. Triedman, MD, and Pedro J. del Nido, MD, Boston and Cambridge, Mass
Real-time 3-dimensional echocardiography provided sufficient spatial resolution and a
satisfactory frame rate to provide a “virtual surgeon’s view” of the relevant anatomy. Beating
heart ASD closure under real-time 3-dimensional echocardiographic guidance is feasible and
applicable for any type of secundum ASD.
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1358 In vitro tissue engineering of a cardiac graft using a degradable scaffold
with an extracellular matrix–like topography
Osamu Ishii, MD, Michael Shin, PhD, Taijiro Sueda, MD, PhD, and Joseph P. Vacanti, MD,
Boston, Mass, and Hiroshima, Japan
Cardiac tissue engineering has the potential to repair impaired hearts by combining cell
transplantation with engineered extracellular matrices. This report demonstrates the formation of
bioengineered cardiac grafts using cardiomyocytes on a novel biodegradable mesh with an
extracellular matrix–like topography in a rat model. Thick contractile grafts were fabricated and
demonstrated good viability in vitro.
1364 Efficient myocyte gene delivery with complete cardiac surgical isolation in
situ
Charles R. Bridges, MD, ScD, Kapil Gopal, MD, David E. Holt, BVSc, Charles Yarnall, BS,
Steven Cole, VMD, Rochelle B. Anderson, DVM, Xiaoqing Yin, MD, Anthony Nelson, BS,
Benjamin W. Kozyak, BS, Zhonglin Wang, MD, James Lesniewski, MD, Leonard T. Su, MD,
Danielle M. Thesier, BS, Hari Sundar, BE, and Hansell H. Stedman, MD, Philadelphia, Pa
We describe a novel cardiac surgical procedure for complete surgical isolation of the heart in
situ with retrograde administration of both vector and endothelial permeabilizing agents to
increase myocyte transduction efficiency. Global cardiac gene delivery in an adult large-animal
model is dramatically more efficient than using a catheter-based technique.
General Thoracic
Surgery
(GTS)
1371 Promoter methylation of the hMLH1 gene and protein expression of human
mutL homolog 1 and human mutS homolog 2 in resected esophageal
squamous cell carcinoma
Ching Tzao, MD, PhD, Han-Sui Hsu, MD, Guang-Huan Sun, MD, PhD, Hsiou-Lei Lai, BS,
Yi-Ching Wang, PhD, Ho-Jui Tung, PhD, Cheng-Ping Yu, MD, PhD,
Yeung-Leung Cheng, MD, PhD, and Shih-Chun Lee, MD, Taipei, Taiwan, Republic of China
Aberrant expression of human mutL homolog 1 (hMLH1) and human mutS homolog 2 protein
is frequently associated with the presence of esophageal squamous cell carcinoma, and aberrant
expression of hMLH1 correlates well with T and N status and with overall stage. Promoter
methylation of the hMLH1 gene is one mechanism responsible for loss of its protein
expression.
1378 Prognostic implication of aberrant promoter hypermethylation of CpG
islands in adenocarcinoma of the lung
Young Tae Kim, MD, PhD, Sun Jung Park, MS, Seung Hee Lee, BS,
Hee Jung Kang, MD, PhD, Seokyung Hahn, PhD, Chang Hyun Kang, MD,
Sook Whan Sung, MD, PhD, and Joo Hyun Kim, MD, PhD, Seoul and Anyang, Korea
DNA hypermethylation of p16INK4(p16), retinoic acid receptor -promoter (RARP2), death-
associated protein kinase (DAPK), O6-methylguanine-DNA-methyltransferase (MGMT), and
glutathione-S-transferase P1 (GSTP1) were tested for pulmonary adenocarcinoma.
Unmethylation of DAPK from cancer tissue and hypermethylation of RARP2 from normal
tissue were risk factors for poor survival. DNA methylation status of CpG islands seems to be
a useful predictor of long-term outcome.
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1385 Surgical results for bronchiectasis based on hemodynamic (functional and
morphologic) classification
Khaled M. Al-Kattan, FRCS, Mohamed A. Essa, MD, Waseem M. Hajjar, FRCS,
Mahmoud H. Ashour, FRCS, Waleed N. Saleh, MD, and Mohamad A. Rafay, FRCS,
Riyadh, Saudi Arabia
In a prospective study of 66 patients with bronchiectasis, hemodynamic (functional and
morphologic) classification provided accurate functional classification. Application in
determining the indications and extent of surgical resection was superior to morphologic
classification alone. Curative resection was achieved in both unilateral and bilateral
bronchiectasis with acceptable morbidity.
1391 Long-segment, supercharged, pedicled jejunal flap for total esophageal
reconstruction
Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J. Miller, MD, David C. Rice, MD,
Stephen G. Swisher, MD, Ara A. Vaporciyan, MD, Jack A. Roth, MD, J. B. Putnam, MD,
W. Roy Smythe, MD, Barry W. Feig, MD, Paul F. Mansfield, MD, Peter W. T. Pisters, MD,
Marla T. Torres, BS, and Garrett L. Walsh, MD, Houston and Temple, Tex, and Nashville,
Tenn
Supercharged pedicled jejunum is a suitable alternative conduit for total esophageal
reconstruction in patients who lack traditional replacement conduits. Excellent functional
outcomes can be achieved, despite the technical complexity of the procedure.
1399 Extensive circumferential endoscopic mucosal resection with a new rigid
esophagoscope: An animal study
Raphaelle Pilloud, MD, Yves Jaquet, MD, and Philippe Monnier, MD, Lausanne, Switzerland
Current EMR techniques are suboptimal for large circumferential mucosal resection. This
experimental study investigated circumferential EMRs of different lengths with a rigid modified
endoscope. Circumferential mucosal resections as long as 5.5 cm were feasible in a single
session and were associated with low morbidity.
1406 Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the
treatment of non–small cell lung cancer
Leah M. Backhus, MD, Nicos A. Petasis, PhD, Jasim Uddin, MS, Axel H. Schönthal, PhD,
Robert D. Bart, MD, Yuanguang Lin, MD, Vaughn A. Starnes, MD, and
Ross M. Bremner, MD, PhD, Los Angeles, Calif
We investigated antineoplastic effects of celecoxib and an analog 2,5-dimethyl celecoxib
lacking COX-2 activity in an NSCLC cell line. Both celecoxib and 2,5-dimethyl celecoxib
inhibited cell proliferation, migration, and invasion, suggesting that these effects may be COX
independent and that therapies could be developed without global COX-2 blockade.
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1413 Predictors of recurrence in thymic tumors: Importance of invasion, World
Health Organization histology, and size
Cameron D. Wright, MD, John C. Wain, MD, Daniel R. Wong, MD, MPH,
Dean M. Donahue, MD, Henning A. Gaissert, MD, Hermes C. Grillo, MD, and
Douglas J. Mathisen, MD, Boston, Mass
Multivariate modeling indicated that Masaoka stage, WHO histology, and size were
independent predictors of recurrence after resection of a thymic tumor. Tumor size of greater
than 8 cm, even when stratified for Masaoka stage III, was an independent risk factor.
1422 Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase
activity induces apoptosis in non–small cell lung cancer in vitro and in vivo
Chadrick E. Denlinger, MD, Brian K. Rundall, DO, and David R. Jones, MD, Charlottesville,
Va
The PI3K/Akt inhibitor LY294002 sensitizes NSCLC to apoptosis induced by the histone
deacetylase inhibitor, butyrate, in part, through NF-B inhibition. Systemic delivery of
LY294002 and butyrate arrested the growth of NSCLC xenografts and induced apoptosis both
in vitro and in vivo.
Cardiothoracic
Transplantation
(TX)
1430 Cell transplantation preserves matrix homeostasis: A novel paracrine
mechanism
Paul W. M. Fedak, MD, PhD, Paul E. Szmitko, BSc, Richard D. Weisel, MD,
Svetlana M. Altamentova, PhD, Nafiseh Nili, PhD, Nobuhisa Ohno, MD, PhD,
Subodh Verma, MD, PhD, Shafie Fazel, MD, MSc, Bradley H. Strauss, MD, PhD, and
Ren-Ke Li, MD, PhD, Toronto, Ontario, Canada
We investigated the capacity of muscle cell transplantation to alter matrix remodeling in
hamster cardiomyopathy. We identified tissue inhibitors of metalloproteinases as potential
paracrine molecular mediators underlying the beneficial effects of cell engraftment on limiting
structural cardiac remodeling.
1440 Hyperoxic ventilation exacerbates lung reperfusion injury
Peter I. Ellman, MD, Jeffrey S. Alvis, MD, Carlos Tache-Leon, MD, Ramesh Singh, MD,
T. Brett Reece, MD, John A. Kern, MD, Curtis G. Tribble, MD, and
Irving L. Kron, MD, Charlottesville, Va
Although prolonged hyperoxia is known to be harmful, the effects of hyperoxic ventilation at
the time of reperfusion are not well known. This study found that hyperoxic ventilation resulted
in an exacerbation of lung reperfusion injury. Thus the normal clinical practice of using a high
fraction of inspired oxygen during lung transplantation should be changed.
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1446 Unexpected donor pulmonary embolism affects early outcomes after lung
transplantation: A major mechanism of primary graft failure?
Takahiro Oto, MD, Marc Rabinov, FRACS, Anne P. Griffiths, FRCNA,
Helen Whitford, FRACP, Bronwyn J. Levvey, RN, Donald S. Esmore, FRACS,
Trevor J. Williams, FRACP, and Gregory I. Snell, FRACP, Melbourne, Australia
Unexpected donor PE was commonly seen (38%) with lung transplantation and was associated
with decreased oxygenation, increased PVR, prolonged mechanical ventilation and ICU stay,
and decreased 1-year survival and might be predicted by a donor death due to trauma with
fracture and a smoking history of greater than 20 pack-years.
Brief Communications e5 Tricuspid valve replacement with a cryopreserved pulmonary homograft
Kuan-Ming Chiu, MD, Tzu-Yu Lin, MD, Jer-Shen Chen, MD, Shao-Jung Li, MD, and
Shu-Hsun Chu, MD, Taipei, Taiwan
e7 Nutritional status in patients on left ventricular assist device support
Nicholas C. Dang, MD, Veli K. Topkara, MD, Brian T. Kim, BS, Brian J. Lee, BS,
Romolo Remoli, and Yoshifumi Naka, MD, PhD, New York, NY
1453 Systolic anterior motion after mitral valve repair: An exceptional cause of
late failure
Rachid Zegdi, MD, PhD, Alain Carpentier, MD, PhD, Fabien Doguet, MD, Alain Berrebi, MD,
Ziad Khabbaz, MD, Sylvain Chauvaud, MD, Alain Deloche, MD, and Jean-Noël Fabiani, MD,
Paris, France
1455 Heparin allergy: Successful desensitization for cardiopulmonary bypass
Kalpaj Parekh, MD, Harold M. Burkhart, MD, Ammar Hatab, MD, Alan Ross, MD, and
Barbara A. Muller, MD, Iowa City, Iowa
1456 Surgical treatment of recurrent transient ischemic attacks and hemoptysis in
a young man with multiple pulmonary arteriovenous malformations
Cliff K. Choong, FRACS, Daniel M. Goodenberger, MD, Daniel Picus, MD, and
Bryan F. Meyers, MD, St Louis, Mo
1459 Geometric change of mitral valve leaflets and annulus after reconstructive
surgery for ischemic mitral regurgitation: Real-time 3-dimensional
echocardiographic study
Yasuko Yamaura, MD, Nozomi Watanabe, MD, Yasuo Ogasawara, PhD, Nozomi Wada, MD,
Takahiro Kawamoto, MD, Eiji Toyota, MD, Takashi Akasaka, MD, Kazuo Tanemoto, and
Kiyoshi Yoshida, MD, Kurashiki, Japan
1462 Antiphospholipid syndrome and right atrial mass
Cristina Basso, MD, PhD, Tomaso Bottio, MD, PhD, Maurizio Rubino, MD,
Amelia Ruffatti, MD, Demetrio Pittarello, MD, Gaetano Thiene, MD, and Gino Gerosa, MD,
Padua, Italy
1464 A Fontan completion through stage I bilateral pulmonary artery banding
for hypoplastic left heart syndrome
Shin Takabayashi, MD, Hideto Shimpo, MD, Yasuhisa Ozu, MD, Kazuto Yokoyama, MD, and
Masaki Kajimoto, MD, Tsu, Japan
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1466 The association of renal tubular acidosis and cyanotic congenital heart
disease
Vladimiro L. Vida, MD, Ricardo Mack, MD, Joaquin Barnoya, MD, MPH,
Luis A. Larrazabal, MD, Randal Lou, MD, and Aldo R. Castañeda, MD, PhD, Guatemala City,
Guatemala
1468 Intraosseous lipoma of the rib
Atilla Eroglu, MD, Cemal Gundogdu, MD, Atila Turkyilmaz, MD, and
Nurettin Karaoglanoglu, MD, Erzurum, Turkey
1470 A new management approach for esophageal perforation
Andria S. Chambers, BS, Terri Jordan, RN, ACNP, Tim McGranahan, RN, ACNP, and
Jon Kiev, MD, Richmond, Va
1471 Dextrocardia is a component of left-sided Poland syndrome
Atilla Eroglu, MD, Duran Yildiz, MD, and Habil Tunc, MD, Istanbul, Turkey
1473 Posterior reversible encephalopathy syndrome after nontransplant cardiac
surgery
John R. Mehall, MD, James L. Leach, MD, and Walter H. Merrill, MD, Cincinnati, Ohio
1475 Neuronal ultrastructure is preserved by fructose-1,6-bisphosphate after
hypothermic circulatory arrest in pigs
Timo Kaakinen, MD, Anita Naukkarinen, MSc, PhD, Hannu Tuominen, MD, PhD,
Pekka Romsi, MD, PhD, Matti Nuutinen, MD, PhD, Fausto Biancari, MD, PhD, and
Tatu Juvonen, MD, PhD, Oulu and Kuopio, Finland
1477 Atherosclerosis of radial arterial graft may increase the potential of vessel
spasm in coronary bypass surgery
Yongde Zhang, MD, Luke Janssen, PhD, and F. Victor Chu, MD, FRCS(C), Hamilton, Ontario,
Canada
Letters to the Editor 1479 Malignant margin in wedge resection for peripheral lung cancer and
adjuvant radiotherapy
Noriyoshi Sawabata, MD, Masayoshi Inoue, MD, Hiroyuki Shiono, MD,
Masahito Monami, MD, and Meinoshin Okumura, MD, Osaka, Japan
1480 Reply
Hani Shennib, MD, Montreal, Quebec, Canada
1480 Whatever the approach, cutting strut chordae would not smell as sweet
Mathias H. Aazami, MD, Mehrdad Salehi, MD, and Roya Satarzadeh, MD, Tehran, Iran
1481 Reply
G. Fayad, MD, T. Modine, MD, and H. Warembourg, MD, Lille, France
1482 Early anticoagulation after aortic valve replacement with bioprostheses:
Time to abandon it?
Francesca di Marco, MD, Giorgio Meneghetti, MD, and Gino Gerosa, MD, Padova, Italy
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1483 Atrial septal defect in infancy: To close or not to close?
Shahzad G. Raja, MRCS, Glasgow, United Kingdom
1483 Reply
Astrid Lammers and John Hess, MD, FESC, Munich, Germany
1483 The evaluation of aortic atherosclerosis and distensibility in aortic valve
stenosis—The role of transesophageal echocardiography
Attila Nemes, MD, PhD, FESC, Tamás Forster, MD, PhD, DSc, FESC, and
Miklo´s Csanády, MD, PhD, DSc, FESC, FACC, Szeged, Hungary
1484 Association between cyclooxygenase and epidermal growth factor receptor
pathways in non–small cell lung cancer
Mehmet Ates, MD, Ozden Altundag, MD, Serdal Aktolga, MD, and
Kadri Altundag, MD, Houston, Tex, and Istanbul and Ankara, Turkey
1485 Reply
Eric Sievers, MD, and R. M. Bremner, MD, PhD, Los Angeles, Calif
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Announcements The American Association for Thoracic Surgery
1488 2005 AATS Scientific Achievement Award Recipient—Alain Carpentier, MD, PhD
1488 Announcement of 2006 Annual Meeting
The Western Thoracic Surgical Association
1489 Announcement of 2006 Annual Meeting
The American Board of Thoracic Surgery
1490 Notices
1490 Requirements for Recertification/Maintenance of Certification
Notices of Correction 1445 Correction of article by Carlos E. Ruiz, MD, Motofumi Iemura, MD, Sibyl
Medie, MS, Peter Varga, MD, William G. Van Alstine, DVM, PhD, Susan Mack,
BA, Anna Deligio, CRT, Neal Fearnot, PhD, Ulf H. Beier, MD, PhD, Dusan
Pavcnik, MD, PhD, Ziyad M. Hijazi, MD, and Matti Kiupel, MD, titled
“Transcatheter placement of a low-profile biodegradable pulmonary valve made
of small intestinal submucosa: A long-term study in a swine model” (2005;130:
477-84)
Table of Contents (continued)
(continued on page 30A)
28A The Journal of Thoracic and Cardiovascular Surgery ● November 2005
ED
ITO
RIA
L
A
CD
CH
D
CSP
ET
G
TS
TX
1445 Correction of article by Thomas Walther, MD, Ardawan Rastan, MD, Ingo
Da¨hnert, MD, Volkmar Falk, MD, PhD, Stefan Jacobs, MD, Friedrich W. Mohr,
MD, PhD, and Martin Kostelka, MD, PhD, titled “A novel adhesion barrier
facilitates reoperations in complex congenital cardiac surgery” (2005;129:359-
63)
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